Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form

Payam Tabarsi; Hossein Vahidi; Ali Saffaei; Seyed Mohammad Reza Hashemian; Hamidreza Jammati; Bahram Daraei; Arash Mahboubi; Farzad Kobarfard; Majid Marjani; Afshin Moniri; Zahra Abtahian; Atefeh Abedini; Alireza Eslaminejad; Jalal Heshmatnia; Maryam Sadat Mirenayat; Atefeh Fakharian; Sharareh Seifi; Mohsen Sadeghi; Alireza Dastan; Sara Haseli; Seyed Alireza Nadji; Raha Eskandari; Sahar Yousefian; Mohammad Varahram; Alireza Zali; Ali Akbar Velayati; Farzaneh Dastan

Iranian Journal of Pharmaceutical Research (2021) - Comments
pubmed: 35194422 doi: 10.22037/ijpr.2021.115510.15401 issn: 1735-0328

Payam Tabarsi, Hossein Vahidi, Ali Saffaei, Seyed Mohammad Reza Hashemian, Hamidreza Jammati, Bahram Daraei, Arash Mahboubi, Farzad Kobarfard, Majid Marjani, Afshin Moniri, Zahra Abtahian, Atefeh Abedini, Alireza Eslaminejad, Jalal Heshmatnia, Maryam Sadat Mirenayat, Atefeh Fakharian, Sharareh Seifi, Mohsen Sadeghi, Alireza Dastan, Sara Haseli